Abstract:Background: Sexual dysfunction may be a side effect of treatment with antipsychotics, antidepressants, and other psychotropic drugs. Aim: To review the evidence concerning male sexual dysfunctions in patients taking psychotropic drugs to provide specific information to nonpsychiatric physicians for the management of these dysfunctions. Methods: A systematic search of Medline and Embase databases was performed up to October 15th, 2020. We included randomized controlled trials comparing the effects of psychotropic drugs versus placebo or versus another drug of the same class, for at least 5 weeks. Outcomes: We considered studies whose male population could be evaluated separately from the female population and with a separate analysis of the different phases of the male sex cycle. Results: We included 41 studies in the final review. There was a significant association between sexual dysfunction and antidepressant drug therapy, compared to placebo (decreased libido OR 1.89, 95% CI:1.40 to 2.56, 22 series, 11 trials, 7706 participants; erectile dysfunction OR = 2.28, 95% CI: 1.31 to 3.97; 11 trials, 3008 participants; ejaculatory dysfunction OR = 7.31, 95% CI: 4.38 to 12.20,19 trials, 3973 participants). When the effects of selective serotonin reuptake inhibitors (SSRIs) were evaluated separately from those of serotonin/norepinephrine reuptake inhibitors (SNRIs), the use of SNRIs but not that of SSRIs was characterized by significantly higher odds of erectile dysfunction compared to placebo. Only limited data were found regarding the effects of antipsychotics on the phases of the male sexual cycle, as it was shown that aripiprazole and risperidone showed lower and higher odds for erectile or ejaculatory dysfunction, respectively, compared to other atypical antipsychotics. Clinical implications: Treatment of male sexual dysfunction in patients taking psychotropics requires a basic knowledge of the different drugs that affect sexual function with different mechanisms. Strengths & limitations: The effects of psychotropic drugs on erectile function and ejaculation were evaluated separately. The great variability of the mechanisms of action makes it difficult to make comparisons between the effects of the different classes of psychotropic drugs. Conclusions: Administration of antipsychotics affects male sexual function with different mechanisms, although the increase in prolactin values associated with the administration of first-generation antipsychotics and some atypical, such as risperidone, seems to play a primary role in determining male sexual dysfunction. Most antidepressants cause decreased libido, ejaculatory and erectile dysfunction, however the administration of SNRIs appears to be possibly associated with a specific risk of erectile dysfunction. Trinchieri M, Trinchieri M, Perletti G, et al. Erectile and Ejaculatory Dysfunction Associated with Use of Psychotropic Drugs: A Systematic Review. J Sex Med 2021;18:1354-1363.

Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research

Risk of renal impairment in atypical antipsychotics: a systematic review and meta-analysis

Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor

An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury

[Adverse events of psychotropic drugs]

New perspectives of drug related kidney diseases and disorders

Adverse Drug Reactions Associated With Drugs Prescribed in Psychiatry: A Retrospective Descriptive Analysis in a Tertiary Care Hospital

Pharmacological treatment for mental health illnesses in adults receiving dialysis: A scoping review

Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review

Prevalence and Influence Factor of Drug-Related Problems in Inpatients with Kidney Disease: A Prospective Single Central Study

Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects

Incidence and Risk Factors of Drug-Induced Kidney Injury in Children: a Systematic Review and Meta-Analysis

Erectile and Ejaculatory Dysfunction Associated with Use of Psychotropic Drugs: A Systematic Review

Inappropriate prescribing in patients with kidney disease: A rapid review of prevalence, associated clinical outcomes and impact of interventions

Drug-associated Kidney Injury in Children: a Disproportionality Analysis of the FDA Adverse Event Reporting System.

New drugs on the horizon for acute kidney injury

Incidence and predictors of adverse drug reactions caused by drug-drug interactions in psychiatric patients: An empirical study

Investigation and analysis of psychotropic adverse event in emergency patients

Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study